These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23618876)

  • 1. The over-expression of ERbeta modifies estradiol effects on mitochondrial dynamics in breast cancer cell line.
    Sastre-Serra J; Nadal-Serrano M; Pons DG; Roca P; Oliver J
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1509-15. PubMed ID: 23618876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dynamics is affected by 17β-estradiol in the MCF-7 breast cancer cell line. Effects on fusion and fission related genes.
    Sastre-Serra J; Nadal-Serrano M; Pons DG; Roca P; Oliver J
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1901-5. PubMed ID: 22824300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.
    Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P
    J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of 17β-estradiol on mitochondrial biogenesis and function in breast cancer cell lines are dependent on the ERα/ERβ ratio.
    Sastre-Serra J; Nadal-Serrano M; Pons DG; Valle A; Oliver J; Roca P
    Cell Physiol Biochem; 2012; 29(1-2):261-8. PubMed ID: 22415095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents.
    Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J
    Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.
    Evers NM; van de Klundert TM; van Aesch YM; Wang S; de Roos WK; Romano A; de Haan LH; Murk AJ; Ederveen AG; Rietjens IM; Groten JP
    Toxicol In Vitro; 2013 Sep; 27(6):1753-61. PubMed ID: 23680332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
    Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
    Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.
    Nadal-Serrano M; Pons DG; Sastre-Serra J; Blanquer-Rosselló Mdel M; Roca P; Oliver J
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2045-51. PubMed ID: 23871935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements.
    Chen JQ; Eshete M; Alworth WL; Yager JD
    J Cell Biochem; 2004 Oct; 93(2):358-73. PubMed ID: 15368362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O; Lattrich C; Springwald A; Ortmann O
    Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
    Rajah TT; Du N; Drews N; Cohn R
    Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin-induced mitochondria fission leads to mitophagy, which attenuates silibinin-induced apoptosis in MCF-7 and MDA-MB-231 cells.
    Si L; Fu J; Liu W; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Onodera S; Ikejima T
    Arch Biochem Biophys; 2020 May; 685():108284. PubMed ID: 32014401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.
    Kallio A; Zheng A; Dahllund J; Heiskanen KM; Härkönen P
    Apoptosis; 2005 Dec; 10(6):1395-410. PubMed ID: 16215679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
    Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lakins J; Lupu R
    Oncol Rep; 2000; 7(1):157-67. PubMed ID: 10601611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.
    Lee SO; Nadiminty N; Wu XX; Lou W; Dong Y; Ip C; Onate SA; Gao AC
    Cancer Res; 2005 Apr; 65(8):3487-92. PubMed ID: 15833885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol.
    Nadal-Serrano M; Sastre-Serra J; Pons DG; Miró AM; Oliver J; Roca P
    J Cell Biochem; 2012 Oct; 113(10):3178-85. PubMed ID: 22615145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17beta-Estradiol inhibits osteoprotegerin production by the estrogen receptor-alpha-positive human breast cancer cell line MCF-7.
    Rachner TD; Schoppet M; Niebergall U; Hofbauer LC
    Biochem Biophys Res Commun; 2008 Apr; 368(3):736-41. PubMed ID: 18252198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.